Literature DB >> 10759328

Cognitive behavior therapy for chronic fatigue syndrome: a case study.

J B Prins1, G Bleijenberg.   

Abstract

The case of a 26-year old woman with Chronic Fatigue Syndrome (CFS) is presented. Multidimensional assessment showing severe debilitating fatigue and considerable psychological, social and occupational impairment confirmed the diagnosis. Cognitive behavior therapy (CBT) was based on a tested causal model of CFS and individual behavioral analyses. Key elements in CBT were process variables from the CFS model, like sense of control, causal attributions, physical activity and focusing on bodily functions. Goals were recovery from fatigue, returning to work and relapse prevention. The course of therapy is described in detail to illustrate difficulties in treating CFS. Assessments were made five times, at baseline and at 8, 14, 21 and 33 months. Comparison of the pretest, post-test and follow-up scores of the outcome variables, fatigue and functional impairment and of the process variables showed clinically significant improvement from the range of CFS patients to the range of healthy controls.

Entities:  

Mesh:

Year:  1999        PMID: 10759328     DOI: 10.1016/s0005-7916(99)00032-4

Source DB:  PubMed          Journal:  J Behav Ther Exp Psychiatry        ISSN: 0005-7916


  2 in total

1.  Examining the influence of biological and psychological factors on cognitive performance in chronic fatigue syndrome: a randomized, double-blind, placebo-controlled, crossover study.

Authors:  Simon Smith; Karen Sullivan
Journal:  Int J Behav Med       Date:  2003

2.  Cognitive behavioural therapy versus multidisciplinary rehabilitation treatment for patients with chronic fatigue syndrome: study protocol for a randomised controlled trial (FatiGo).

Authors:  Desirée C W M Vos-Vromans; Rob J E M Smeets; Leonie J M Rijnders; René R M Gorrissen; Menno Pont; Albère J A Köke; Minou W M G C Hitters; Silvia M A A Evers; André J Knottnerus
Journal:  Trials       Date:  2012-05-30       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.